MARKER THERAPEUTICS, INC. Operating Expenses
MARKER THERAPEUTICS, INC. (MRKR) reported Operating Expenses of $2.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- MARKER THERAPEUTICS, INC. operating expenses for the quarter ending 2026-06-30 was $2.62M, a 48.84% decline year-over-year.
- MARKER THERAPEUTICS, INC. operating expenses for the quarter ending 2026-03-31 was $4.07M, a 17.86% decline year-over-year.
- MARKER THERAPEUTICS, INC. operating expenses for the quarter ending 2025-12-31 was $2.99M, a 51.13% decline year-over-year.
- MARKER THERAPEUTICS, INC. operating expenses for the quarter ending 2025-09-30 was $3.37M, a 22.10% decline year-over-year.
- MARKER THERAPEUTICS, INC. operating expenses for fiscal 2025 was $16.44M, a 7.18% decline from fiscal 2024.
- MARKER THERAPEUTICS, INC. operating expenses for fiscal 2024 was $17.71M, a 1.02% decline from fiscal 2023.
- MARKER THERAPEUTICS, INC. operating expenses for fiscal 2023 was $17.89M, a 23.22% decline from fiscal 2022.
- MARKER THERAPEUTICS, INC. operating expenses for fiscal 2022 was $23.30M, a 42.77% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.62M 10-Q · filed 2026-08-14 | $6.69M 10-Q · filed 2026-08-14 | $9.68M derived: sum of 3 quarters · filed 2026-08-14 | $13.05M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $4.07M 10-Q · filed 2026-05-15 | $7.06M derived: sum of 2 quarters · filed 2026-05-15 | $10.43M derived: sum of 3 quarters · filed 2026-05-15 | $15.55M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $6.36M derived: sum of 2 quarters · filed 2026-03-18 | $11.48M derived: sum of 3 quarters · filed 2026-08-14 | $16.44M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $3.37M 10-Q · filed 2025-11-13 | $8.49M derived: sum of 2 quarters · filed 2026-08-14 | $13.45M 10-Q · filed 2025-11-13 | $19.56M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $5.12M 10-Q · filed 2026-08-14 | $10.08M 10-Q · filed 2026-08-14 | $16.19M derived: sum of 3 quarters · filed 2026-08-14 | $20.52M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $4.96M 10-Q · filed 2026-05-15 | $11.07M derived: sum of 2 quarters · filed 2026-05-15 | $15.40M derived: sum of 3 quarters · filed 2026-05-15 | $18.87M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $10.44M derived: sum of 2 quarters · filed 2026-03-18 | $13.92M derived: sum of 3 quarters · filed 2026-03-18 | $17.71M 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | $4.33M 10-Q · filed 2025-11-13 | $7.80M derived: sum of 2 quarters · filed 2025-11-13 | $11.60M 10-Q · filed 2025-11-13 | $15.59M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $3.48M 10-Q · filed 2025-08-14 | $7.27M 10-Q · filed 2025-08-14 | $11.26M derived: sum of 3 quarters · filed 2025-08-14 | $14.72M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $3.79M 10-Q · filed 2025-05-15 | $7.79M derived: sum of 2 quarters · filed 2025-05-15 | $11.25M derived: sum of 3 quarters · filed 2025-05-15 | $16.14M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $7.45M derived: sum of 2 quarters · filed 2025-03-31 | $12.35M derived: sum of 3 quarters · filed 2025-03-31 | $17.89M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $3.46M 10-Q · filed 2024-11-14 | $8.35M derived: sum of 2 quarters · filed 2024-11-14 | $13.90M 10-Q · filed 2024-11-14 | $17.70M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $4.90M 10-Q · filed 2024-08-14 | $10.44M 10-Q · filed 2024-08-14 | $14.24M derived: sum of 3 quarters · filed 2024-08-14 | $21.06M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $5.54M 10-Q · filed 2024-05-15 | $9.79M 10-Q · filed 2023-05-15 | $9.34M derived: sum of 2 quarters · filed 2024-05-15 | $16.17M derived: sum of 3 quarters · filed 2024-05-15 | $22.23M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $10.62M derived: sum of 2 quarters · filed 2024-03-26 | $16.68M derived: sum of 3 quarters · filed 2024-03-26 | $23.30M 10-K · filed 2024-03-26 | $38.96M 10-K · filed 2023-03-22 | |||
| 2022-09-30 | $6.83M 10-Q · filed 2023-11-09 | $10.97M 10-Q · filed 2022-11-10 | $12.89M derived: sum of 2 quarters · filed 2023-11-09 | $19.51M 10-Q · filed 2023-11-09 | $31.80M 10-Q · filed 2022-11-10 | $34.65M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $6.06M 10-Q · filed 2023-08-14 | $10.07M 10-Q · filed 2022-08-11 | $12.68M 10-Q · filed 2023-08-14 | $20.83M 10-Q · filed 2022-08-11 | $27.82M derived: sum of 3 quarters · filed 2023-08-14 | $37.85M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $10.76M 10-Q · filed 2023-05-15 | $21.77M derived: sum of 2 quarters · filed 2023-05-15 | $31.79M derived: sum of 3 quarters · filed 2023-05-15 | $42.70M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $11.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $21.03M derived: sum of 2 quarters · filed 2023-03-22 | $31.94M derived: sum of 3 quarters · filed 2023-03-22 | $40.72M 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $10.02M 10-Q · filed 2022-11-10 | $20.93M derived: sum of 2 quarters · filed 2022-11-10 | $29.71M 10-Q · filed 2022-11-10 | $38.22M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $10.91M 10-Q · filed 2022-08-11 | $19.69M 10-Q · filed 2022-08-11 | $28.20M derived: sum of 3 quarters · filed 2022-08-11 | $35.57M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $8.78M 10-Q · filed 2022-05-13 | $17.29M derived: sum of 2 quarters · filed 2022-05-13 | $24.67M derived: sum of 3 quarters · filed 2022-05-13 | $31.49M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $8.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $15.88M derived: sum of 2 quarters · filed 2022-03-17 | $22.71M derived: sum of 3 quarters · filed 2022-03-17 | $29.35M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $7.38M 10-Q · filed 2021-11-10 | $14.20M derived: sum of 2 quarters · filed 2021-11-10 | $20.84M 10-Q · filed 2021-11-10 | $26.42M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $6.82M 10-Q · filed 2021-08-10 | $13.47M 10-Q · filed 2021-08-10 | $19.04M derived: sum of 3 quarters · filed 2021-08-10 | $24.70M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | $6.64M 10-Q · filed 2021-05-12 | $12.22M derived: sum of 2 quarters · filed 2021-05-12 | $17.87M derived: sum of 3 quarters · filed 2021-05-12 | $23.75M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $11.23M derived: sum of 2 quarters · filed 2021-03-09 | $17.10M derived: sum of 3 quarters · filed 2021-03-09 | $22.74M 10-K · filed 2021-03-09 | ||||
| 2019-09-30 | $5.65M 10-Q · filed 2020-11-09 | $11.53M derived: sum of 2 quarters · filed 2020-11-09 | $17.17M 10-Q · filed 2020-11-09 | $153.04M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $5.87M 10-Q · filed 2020-08-10 | $11.51M 10-Q · filed 2020-08-10 | $147.38M derived: sum of 3 quarters · filed 2020-08-10 | $151.81M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $5.64M 10-Q · filed 2020-05-11 | $141.51M derived: sum of 2 quarters · filed 2020-05-11 | $145.94M derived: sum of 3 quarters · filed 2020-05-11 | $150.82M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $135.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $140.30M derived: sum of 2 quarters · filed 2020-03-12 | $145.18M derived: sum of 3 quarters · filed 2020-03-12 | $148.38M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | $4.43M 10-Q · filed 2019-11-12 | $9.31M derived: sum of 2 quarters · filed 2019-11-12 | $12.51M 10-Q · filed 2019-11-12 | $15.19M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $4.88M 10-Q · filed 2019-08-09 | $8.08M 10-Q · filed 2019-08-09 | $10.76M derived: sum of 3 quarters · filed 2019-08-09 | $14.93M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $3.20M 10-Q · filed 2019-05-10 | $5.88M derived: sum of 2 quarters · filed 2019-05-10 | $10.05M derived: sum of 3 quarters · filed 2019-05-10 | $12.44M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $6.85M derived: sum of 2 quarters · filed 2019-03-15 | $9.25M derived: sum of 3 quarters · filed 2019-03-15 | $11.66M 10-K · filed 2019-03-15 | ||||
| 2017-09-30 | $4.17M 10-Q · filed 2018-11-13 | $6.57M derived: sum of 2 quarters · filed 2018-11-13 | $8.98M 10-Q · filed 2018-11-13 | $10.57M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $2.39M 10-Q · filed 2018-08-09 | $4.81M 10-Q · filed 2018-08-09 | $6.40M derived: sum of 3 quarters · filed 2018-08-09 | $9.12M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $2.42M 10-Q · filed 2018-05-15 | $4.01M derived: sum of 2 quarters · filed 2018-05-15 | $6.73M derived: sum of 3 quarters · filed 2018-05-15 | $9.16M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | $4.31M derived: sum of 2 quarters · filed 2018-03-23 | $6.74M derived: sum of 3 quarters · filed 2018-03-23 | $8.49M 10-K · filed 2018-03-23 | ||||
| 2016-09-30 | $2.72M 10-Q · filed 2017-11-14 | $5.15M derived: sum of 2 quarters · filed 2017-11-14 | $6.90M 10-Q · filed 2017-11-14 | |||||
| 2016-06-30 | $2.43M 10-Q · filed 2017-08-07 | $4.18M 10-Q · filed 2017-08-07 | ||||||
| 2016-03-31 | $1.75M 10-Q · filed 2017-05-05 | |||||||
| 2015-09-30 | $1.74M 10-Q/A · filed 2016-04-14 | $3.90M 10-Q/A · filed 2016-04-14 | ||||||
| 2014-09-30 | $1.38M 10-Q/A · filed 2016-04-14 | $2.98M 10-Q/A · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |